2.65
price down icon2.57%   -0.07
after-market アフターアワーズ: 2.63 -0.02 -0.75%
loading

OncoCyte Corporation (OCX) 最新ニュース

pulisher
Feb 21, 2025

OncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025
pulisher
Feb 15, 2025

Oncocyte secures $29.1 million to advance FDA assay - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Broadwood Partners acquires OncoCyte shares worth $9.24 million - MSN

Feb 14, 2025
pulisher
Feb 13, 2025

OncoCyte stock hits 52-week low at $1.92 amid market challenges - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Oncocyte corp's Patrick Smith acquires shares worth $2.2 million - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Oncocyte corp CFO buys $200,000 in stock - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Oncocyte corp CFO buys $200,000 in stock By Investing.com - Investing.com Canada

Feb 12, 2025
pulisher
Feb 11, 2025

Oncocyte Corp CFO Acquires 97,561 Shares in Private Placement - TradingView

Feb 11, 2025
pulisher
Feb 11, 2025

Oncocyte corp's Patrick Smith acquires shares worth $2.2 million By Investing.com - Investing.com South Africa

Feb 11, 2025
pulisher
Feb 11, 2025

Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - The Manila Times

Feb 11, 2025
pulisher
Feb 11, 2025

Exclusive: Oncocyte (OCX) CEO & CFO to Meet Top Investors at BTIG's Elite Healthcare Conference - StockTitan

Feb 11, 2025
pulisher
Feb 11, 2025

Oncocyte Corp enters into securities purchase agreements - Medical Buyer

Feb 11, 2025
pulisher
Feb 10, 2025

Broadwood Partners acquires OncoCyte shares worth $9.24 million By Investing.com - Investing.com Nigeria

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte Prices $29 Million Stock Offerings -February 10, 2025 at 12:41 pm EST - Marketscreener.com

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte prices $29.1M equity offering - MSN

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte Secures $29.1Mln Funding Led By Bio-Rad To Advance Transplant Diagnostics, Stock Down - Nasdaq

Feb 10, 2025
pulisher
Feb 10, 2025

OncoCyte’s $29.1M Funding Through Securities Agreements - TipRanks

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte Prices $29.1 Million Equity Offering - The Manila Times

Feb 10, 2025
pulisher
Feb 10, 2025

ForexTV | Small Business Resources - ForexTV.com

Feb 10, 2025
pulisher
Feb 10, 2025

Oncocyte (OCX) Secures Game-Changing $29.1M Investment to Revolutionize Early Transplant Rejection Detection - StockTitan

Feb 10, 2025
pulisher
Feb 04, 2025

Oncocyte corp investor Patrick Smith buys $1,839 in shares By Investing.com - Investing.com South Africa

Feb 04, 2025
pulisher
Feb 04, 2025

Oncocyte corp investor Patrick Smith buys $1,839 in shares - MSN

Feb 04, 2025
pulisher
Feb 01, 2025

Oncocyte Corporation (NASDAQ:OCX) Shares Rebounded 7.25% From Their Lows – But Can They Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 16, 2025

Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock - Investing.com India

Jan 16, 2025
pulisher
Jan 16, 2025

Oncocyte corp shareholder Patrick W Smith acquires $34,114 in stock By Investing.com - Investing.com Australia

Jan 16, 2025
pulisher
Jan 15, 2025

OncoCyte (STU:7OC0) PS Ratio : 47.04 (As of Jan. 15, 2025) - GuruFocus.com

Jan 15, 2025
pulisher
Jan 14, 2025

OncoCyte Co. (NASDAQ:OCX) Shares Bought by Geode Capital Management LLC - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

StockNews.com Initiates Coverage on OncoCyte (NASDAQ:OCX) - Defense World

Jan 13, 2025
pulisher
Jan 11, 2025

OncoCyte Corporation (NASDAQ: OCX) Enters Amendment to Lease Agreement with Induce Biologics USA, Inc. and Cushing Ventures, LLCOn January 2, 2025, Oncocyte Corporation announced in a Form 8-K filing that it has entered into an Amendment to a - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

Oncocyte Corp amends lease agreement, sets expiration date By Investing.com - Investing.com Nigeria

Jan 09, 2025
pulisher
Jan 08, 2025

Oncocyte Corp amends lease agreement, sets expiration date - Investing.com

Jan 08, 2025
pulisher
Jan 08, 2025

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - Markets Insider

Jan 08, 2025
pulisher
Jan 08, 2025

Oncocyte names Dr. Paul Billings as Consulting CMO - Investing.com India

Jan 08, 2025
pulisher
Jan 08, 2025

Oncocyte Taps Harvard-Trained Diagnostics Veteran Dr. Paul Billings as Chief Medical Officer - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Medicare expands coverage for kidney transplant test By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney - The Manila Times

Jan 07, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):